Vas Narasimhan, global head development at Novartis Pharmaceuticals, talks about the importance of digital nowadays in pharmaceutical companies. He also emphasis the need to combine different cells therapies to efficiently cure complex diseases. Of course for us, it’s also a confirmation of HCS future developments to test the efficiency of these combinations.

Demain, il y aura la convergence de nombreuses technologies : les dispositifs médicaux, les capteurs… Personne ne sait encore comment cela va marcher. Nous avançons à travers plusieurs axes. En investissant dans des entreprises via des fonds de capital-risque ou en engageant de grands partenariats, avec Google dans les lentilles, Qualcomm ou encore Microsoft.

Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.